{"id":"https://openalex.org/W7225157608","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","title":"133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma","display_name":"133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225157608","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0133"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0133","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A147.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A147.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160470235","display_name":"Mei Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei Han","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077910865","display_name":"Mengxuan Jia","orcid":"https://orcid.org/0000-0001-9173-1084","observed_orcids":["https://orcid.org/0000-0001-9173-1084"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mengxuan Jia","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100372300","display_name":"Bin Wang","orcid":"https://orcid.org/0000-0001-6357-048X","observed_orcids":["https://orcid.org/0000-0001-6357-048X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Wang","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160530357","display_name":"Christina Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Shen","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008745211","display_name":"Ryan V. Quiroz","orcid":"https://orcid.org/0000-0001-6840-9636","observed_orcids":["https://orcid.org/0000-0001-6840-9636"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Quiroz","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160541183","display_name":"Jianzhong Wen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianzhong Wen","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5057303784","display_name":"Ian W. Knemeyer","orcid":"https://orcid.org/0000-0001-6254-882X","observed_orcids":["https://orcid.org/0000-0001-6254-882X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian Knemeyer","raw_affiliation_strings":["Merck & Co Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A147","last_page":"A147"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.015699999406933784,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sacituzumab-tirumotecan","display_name":"sacituzumab tirumotecan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9860000014305115},{"id":"https://openalex.org/keywords/trop2","display_name":"TROP2","score":0.8840000033378601},{"id":"https://openalex.org/keywords/ph-sensitive-linker","display_name":"pH-sensitive linker","score":0.753000020980835},{"id":"https://openalex.org/keywords/payload-release","display_name":"payload release","score":0.875},{"id":"https://openalex.org/keywords/biotransformation","display_name":"biotransformation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/drug-albumin-binding","display_name":"drug-albumin binding","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C27881333","wikidata":"https://www.wikidata.org/wiki/Q864895","display_name":"Biotransformation","level":3,"score":0.8510000109672546},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.7796000242233276},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7694000005722046},{"id":"https://openalex.org/C3020134792","wikidata":"https://www.wikidata.org/wiki/Q79749","display_name":"Human plasma","level":2,"score":0.7394000291824341},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7124000191688538},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4575999975204468},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3752000033855438},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.3156000077724457},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.2955000102519989},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.25380000472068787}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0133","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A147.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0133","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0133","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A147.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225157608.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3003211156","https://openalex.org/W2783421486","https://openalex.org/W7225154634","https://openalex.org/W4410993904","https://openalex.org/W4403337177","https://openalex.org/W7148977734","https://openalex.org/W3132209771","https://openalex.org/W2973834824","https://openalex.org/W4410995056","https://openalex.org/W2767525659"],"abstract_inverted_index":{"Background":[0],"Sacituzumab":[1],"tirumotecan":[2],"(sacTMT)":[3],"is":[4],"a":[5,42,262,270],"TROP2-directed":[6],"antibody\u2013drug":[7],"conjugate":[8],"(ADC)":[9],"currently":[10],"being":[11],"developed":[12],"for":[13,122,169],"multiple":[14],"common":[15],"cancers.":[16],"It":[17],"employs":[18],"methylsulfonyl":[19],"pyrimidine-based":[20],"conjugation":[21],"chemistry,":[22],"enabling":[23,285],"an":[24,277],"irreversible":[25,69,219,278],"coupling":[26,70,220,279,299],"in":[27,45,52,104,119,266,330,337],"the":[28,33,46,65,75,144,173,222,281,295,301,317,325],"connection":[29,44,272],"between":[30,273,280],"linker-payload":[31,73,134,175],"and":[32,54,77,85,115,131,157,192,230,237,275,283,307,332,350],"antibody":[34,282],"relative":[35],"to":[36,49,74,124,177,221,260,300,314],"conventional":[37],"ADCs.":[38],"SacTMT":[39,257],"also":[40],"incorporates":[41],"pHsensitive":[43,271],"linker\u2013payload":[47,274],"designed":[48],"enhance":[50],"stability":[51,329],"circulation":[53,331],"maximize":[55],"intratumoral":[56],"payload":[57,67,90,97,146,150,163,231,249,287,335],"release":[58,91,147,151,232,336],"via":[59,98,179,205,233],"pHdependent":[60,66,89],"cleavage.":[61],"Here,":[62],"we":[63],"evaluated":[64],"release,":[68,250],"moiety":[71],"of":[72,79,102,213,291,297,316],"antibody,":[76,302],"biotransformation":[78],"sacTMT":[80,103,184,200],"alongside":[81],"sacituzumab":[82],"govitecan":[83],"(SG)":[84],"trastuzumab":[86],"vedotin":[87],"(TRA-V).Methods":[88],"was":[92,166,258],"assessed":[93],"by":[94,253],"quantifying":[95],"free":[96],"LC\u2013MS":[99,141],"following":[100],"incubation":[101,155],"buffers":[105],"across":[106],"physiologically":[107],"relevant":[108],"pH":[109,339],"conditions.":[110],"For":[111],"biotransformation,":[112],"sacTMT,":[113],"SG,":[114],"TRA-V":[116,193,241],"were":[117,135],"incubated":[118],"human":[120],"plasma":[121,161],"up":[123],"14":[125],"days.":[126],"Biotransformation":[127],"pathways,":[128],"DAR":[129,201,227,244,318],"reduction,":[130],"cysteinetrapped":[132,292],"deconjugated":[133,174],"studied":[136],"using":[137],"immunoaffinity":[138],"capture":[139],"followed":[140],"analysis.Results":[142],"During":[143,160],"pH-dependent":[145],"assay,":[148],"sac-TMT":[149,326],"increased":[152],"with":[153,210,218,247],"longer":[154],"time":[156],"decreasing":[158],"pH.":[159],"incubation,":[162],"mass":[164,196],"balance":[165],"not":[167,186],"observed":[168],"TRA-V,":[170,308],"indicating":[171],"that":[172,199,267,324],"binds":[176],"albumin":[178],"maleimide":[180],"exchange.In":[181],"cysteinespiked":[182],"plasma,":[183],"did":[185],"form":[187],"cysteinyl":[188],"adducts,":[189],"whereas":[190],"SG":[191,225,306],"did.":[194],"Intact":[195],"analysis":[197],"confirmed":[198],"value":[202,228,245],"reduction":[203,229,246,315],"occurred":[204],"linker":[206,235,265,327],"cleavage":[207,236],"(amide":[208],"hydrolysis),":[209],"no":[211],"evidence":[212],"reverse":[214,238,254,310],"Michael":[215,239,255,311],"deconjugation,":[216],"consistent":[217],"antibody.In":[223],"contrast,":[224],"exhibited":[226],"both":[234],"deconjugation.":[240],"showed":[242],"rapid":[243],"slower":[248],"predominantly":[251],"driven":[252],"deconjugation.Conclusions":[256],"shown":[259],"have":[261],"unique":[263],"bifunctional":[264],"it":[268,304],"combines":[269],"has":[276],"linker-payload,":[284],"controlled":[286],"release.":[288],"The":[289],"absence":[290],"adducts":[293],"confirms":[294],"irreversibility":[296],"its":[298],"distinguishing":[303],"from":[305],"where":[309],"deconjugation":[312],"contributes":[313],"value.":[319],"Altogether,":[320],"these":[321],"data":[322],"indicate":[323],"provides":[328],"enables":[333],"efficient":[334],"low":[338],"environments,":[340],"such":[341],"as":[342],"intracellular":[343],"lysosomes,":[344],"thereby":[345],"potentially":[346],"optimizing":[347],"tumor":[348],"targeting":[349],"therapeutic":[351],"index.":[352]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}